Andrew Navia is interested in applying single cell sequencing to clinical samples to better diagnose and treat cancers and infectious diseases. His interests in drug discovery and entrepreneurship mesh well with the Shalek lab’s research interests and culture. As a first-year graduate student in chemistry, he continues to learn about the intricacies of sequencing while teaching chemistry lab to non-majors, developing independent projects and taking courses. Andrew’s undergraduate science background is in medicinal organic synthesis. He earned a bachelor’s degree in chemistry at Emory University while working in Professor Dennis Liotta’s lab. As a native of Lexington Massachusetts, Andrew is thrilled to be back in New England after five great years in Atlanta.

Optofluidic real-time cell sorter for longitudinal CTC studies in mouse models of cancer
  • Hamza B. et al.,
  • PNAS,
  • 2019
  • Technology
  • Cancer
  • Computational Methods
  • R&D
  • Biology
  • Jay Prakadan
  • Andrew Navia
  • Peter Winter
  • Riley Drake
  • Alejandro Gupta
  • Alex K. Shalek
Initiation of Antiviral B Cell Immunity Relies on Innate Signals from Spatially Positioned NKT Cells
  • Gaya M. et al.,
  • Cell,
  • 2017
  • Genomics
  • Immunology
  • Andrew Navia
  • Alex K. Shalek